Janney Montgomery Scott’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Janney Montgomery Scott’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-65,500	Closed	-$23K	–	2181
2018 Q2	$23K	Buy	65,500 +9,000	+16%	+$7.38K	﹤0.01%	1982
2018 Q1	$85K	Buy	56,500 +12,000	+27%	+$20.9K	﹤0.01%	1907
2017 Q4	$63K	Buy	44,500 +10,000	+29%	+$16.4K	﹤0.01%	1900
2017 Q3	$79K	Buy	34,500 +500	+1%	+$669	﹤0.01%	1795
2017 Q2	$46K	Buy	34,000 +5,500	+19%	+$7.94K	﹤0.01%	1721
2017 Q1	$61K	Buy	28,500 +8,500	+43%	+$31.9K	﹤0.01%	1717
2016 Q4	$88K	Hold	20,000	–	–	﹤0.01%	1630
2016 Q3	$97K	Buy	+20,000	New	+$91.2K	﹤0.01%	1470
2016 Q2	–	Sell	-17,750	Closed	-$63K	–	1347
2016 Q1	$63K	Buy	+17,750	New	+$91.5K	﹤0.01%	1236

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Janney Montgomery Scott's ARLZ Position: Q3 2018 in Review

Janney Montgomery Scott sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 65,500 shares — an estimated $23K sold.

Janney Montgomery Scott first reported a position in ARLZ in Q1 2016 and held it in 9 quarters. The position peaked at $97K in Q3 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

Janney Montgomery Scott reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
Janney Montgomery Scott sold 65,500 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $23K.
Janney Montgomery Scott first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 9 quarters.
Janney Montgomery Scott's Aralez Pharmaceuticals Inc. position peaked at $97K in Q3 2016.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Janney Montgomery Scott's 13F filing for Q3 2018, filed 5 Nov 2018.